MarkWide Research

Sale!

Medical Simulation Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: July, 2022
No of Pages: 172
Delivery Format: PDF + Excel

$2,950.00

The global medical simulation market was valued at $1687.50 million in 2020. It is expected to grow to $6,688.60 million by 2030. This will represent a 14.7% CAGR from 2021 to 2030. A virtual replica of an actual process or abstract is a medical simulation. This simulation is used to train and teach people in different medical professions. Simulations can be conducted in the classroom, in real-world scenarios, or in specially designed simulation areas.

Medical simulation is a method of training healthcare workers. It involves using virtual reality or simulation models to simulate real-life situations and practice procedures. Medical simulation is a systematic way to learn clinical skills, rather than the traditional apprentice learning style. You can have simulated patients or artificial patients. There are also instructional materials that include detailed animations and casualty assessments in war and national security scenarios—holographic simulations to support virtual health operations. Simulators can be used to replace actual patients.

Simulating a real-world process is one way to use simulation to help students achieve their educational goals. Simulated medical education is any activity that uses simulation aides to simulate clinical conditions.

The increase in medical simulation use is mainly due to simulation in healthcare. An increase in deaths as a result of medical errors; and the need for better patient safety outcomes are some reasons for the expansion of the medical simulation market. Augmented and virtual reality are becoming increasingly popular. They have proven helpful for communication and teaching in healthcare simulation programs. Virtual reality (V.R.), for example, can be used to help distant students perform surgeries or other processes. This allows students to apply their knowledge and correct their mistakes. Virtual and augmented reality can be used in healthcare simulation to enhance hands-on training, such as performing surgery or inserting I.V.s.

Simulating healthcare professionals can help them improve their patient safety by increasing their confidence, knowledge, expertise, and knowledge. Simulation offers a way to improve patient safety and reduce medical errors by better training and educating clinicians. Simulation has been used in professional education programs to improve clinical and critical thinking skills for low-risk, high-frequency events. Simulators on the market provide consistent, repeatable training and expose you to more patients and scenarios than standard clinical practice.

Simulation is a growing industry due to technological advances in the medical field. Advanced medical procedures and new devices such as IntraCardiac echocardiography (ICE), mechanical ventilation enhancements, and cardiac assist devices require advanced training solutions, such as simulation, for product development and training.

The high cost of medical simulators is a significant obstacle to widespread adoption. Simulators used in this scenario are costly and require regular updates and maintenance. Operators must be trained in the use of software and hardware. This takes additional time and money. Simulators require a lot of maintenance, which can hinder the growth of the healthcare simulation market.

The Impact of Covid-19 on the Medical Simulation Market (Pre and Post Analysis)

Due to the COVID-19 pandemic, a large number of hospitals and clinics around the world were restructured to provide more hospital beds for COVID-19 patients. Due to the rapidly increasing COVID-19 cases, non-essential procedures caused a backlog and harmed the market. Virtual simulation technology was used during the pandemic to improve and strengthen patient and procedural care skills. The market for virtual medical simulation is expected to grow due to the increased use of screen-based simulations, augmented reality/A.R., and blended reality/V.R.

There are also opportunities in emerging markets that have high potential. This is due to the improved healthcare infrastructure, rise in unmet medical needs, and increased prevalence of medical errors. The market is expected to expand rapidly due to the availability of facilities that offer minimally invasive procedures. This will increase the potential for market players to invest in healthcare simulation.

Segmentation of the Medical Simulation Market

The medical simulation market can be segmented based on product & services, fidelity, end-users, and location. It can be divided by product and service into web-based, model-based, and training services. The model-based sim segment can be further divided into the surgical simulation, patient simulation, and ultrasound simulator. Patient simulation can be divided into manikin simulation, task trainer simulation, hybrid manikin simulation (with A.R.), and standardized patient simulators. Laparoscopic, arthroscopic, and hybrid surgical simulators are available for surgical simulation. Ultrasound simulation can also be divided into anesthesia and radiology, cardiology, emergency medicine (ICU), obstetrics & Gynecology, radiology, and other areas.

In addition, the web-based simulation segment is classified into simulation software, performance-recording software, virtual tutors, and learning management software. The segment of simulation training services includes vendor-based training, custom consulting, and educational society.

The market for medical simulations can be divided into three categories based on low fidelity (medium fidelity), high fidelity (high fidelity), and high fidelity. It can be divided by end-user into hospitals, military organizations, and academic institutions.

Region analyzes the market for medical simulation. It includes North America (the U.S. and Canada), Europe (Germany and France), Europe (the U.K., Italy and Spain and the rest of Europe), Asia-Pacific, Japan, China, India, and Australia, as well LAMEA Brazil, South Africa, and Saudi Arabia.

Segment Review

Based on product and service, the model-based simulation segment dominated in 2020 and will continue to dominate the market during the forecast period. This is due to increased patient safety, minimally invasive surgery, and limited access to live patients.

Based on fidelity, the low fidelity segment dominated the market in 2020 and will continue to dominate during the forecast period. This is due to its simplicity and low cost.

Academic institutions showed the greatest growth by end-user in 2020 and will continue to do so during the forecast period.

North America held the largest share of the global medical simulator market in 2020 and will remain dominant over the forecast period. This can be attributed to the rise in medical errors, the presence of key players, increased healthcare spending, technological advances, and the rise of government initiatives in this Region. But, Asia-Pacific is expected to see significant growth due to the population increase, availability of medical simulation services, and increased investments in the healthcare sector.

Global medical simulation market players include CAE, Inc., Gaumard Scientific Company, Inc., Intelligent Ultrasound Group Plc., Kyoto KSynaptive Medical, Kagaku Co. Ltd., Surgical Science, Laerdal Medical AS, Limbs and Things, Ltd., HRV Simulation, Mentice AB, Inovus, Operative Experience, Inc., Simulab Corporation, and VirtaMed AG.

Key Benefits for Stakeholders

  • This study examines the market for medical simulation, as well as the future trends and estimations. It also identifies the most likely investment opportunities.
  • This report provides a quantitative analysis of the market for medical simulations from 2021 to 2030 to help stakeholders capitalize on the current market opportunities.
  • An extensive analysis of the market, based on services and procedures, helps to understand the trends within the medical simulation industry.
  • To understand the competitive outlook for the medical simulator market, we analyze the strategies of key players.

Medical Simulation Market Report Scope and Segmentation

ATTRIBUTESDETAILS
ESTIMATED YEAR2022
BASE YEAR2021
FORECAST YEAR2030
HISTORICAL YEAR2017-2021
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

Key Market Segments

By Product & Services

  • Simulator based on models
  • Patient Simulation
      • Simulator for Task Trainer
  • Manikin-based Simulation
        • Adult
        • Pediatric
      • Neonatal
      • Simulation-based on Hybrid Manikin (with A.R.).
    • Standardized Patient Simulation
  • Surgical Simulation
      • Laparoscopic Surgical Simulators
      • Simulators for Arthroscopic Surgery
      • Simulators for Cardiovascular Simulators
      • Simulators for Gynecology
      • Simulators for Orthopedic Surgery
      • Spine Simulators
      • Endovascular Simulators
    • Other
  • Ultra-simulation
      • Anesthesia
      • Cardiology
      • Emergency Medicine
      • Intensive Care Unit
      • OB/GYN
      • Radiology
    • Other (Urology and General Nursing, Pediatrics).
  • Web-based Simulation
      • Simulation Software
      • Performance Recording Software
      • Virtual Tutors
    • Learning Management Software
    • Simulation Training Services
    • Vendor-based training
    • Custom Consulting Services
    • Educational Societies

By Fidelity

  • Low-fidelity
  • Medium-fidelity
  • High-fidelity

End-User

  • Academic Institutions
  • Hospitals
  • Military Organizations

by Region

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • Italy
      • France
      • UK
      • Spain
      • Poland
      • Russia
      • The Netherlands
      • Norway
      • Czech Republic
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Indonesia
      • Malaysia
      • Thailand
      • Singapore
      • Australia & New Zealand
      • Rest of Asia Pacific
    • South America
      • Brazil
      • Argentina
      • Colombia
      • Rest of South America
    • The Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Northern Africa
      • Rest of MEA

Key Market Participants

  • CAE, Inc.
  • Gaumard Scientific Company, Inc.
  • Intelligent Ultrasound Group Plc.
  • Synovus
  • Synaptive Medical
  • Kyoto Kagaku Co. Ltd.
  • Laerdal Medical AS
  • HRV Simulation
  • Surgical Science
  • Limbs and Things, Ltd.
  • Mentice AB
  • Operative Experience, Inc.
  • Similar Corporation
  • VirtaMed AG
  • Others

Table of Contents

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profile in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porters five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in use of virtual and augmented reality
3.5.1.2.Assured improvement in patient safety outcomes
3.5.1.3.Benefits of medical simulation
3.5.1.4.Technological advancements in medical field
3.5.1.5.Increase in demand for virtual training

3.5.2.Restraints

3.5.2.1.High cost for setting up simulators
3.5.2.2.Limitation to imitate a complete real situation

3.5.3.Opportunity

3.5.3.1.Lucrative opportunities in emerging markets

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the medical simulation market

CHAPTER 4:GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE

4.1.Overview

4.1.1.Market size and forecast

4.2.Model-based simulation

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type

4.2.4.1.Patient simulation

4.2.4.1.1.Market size and forecast
4.2.4.1.2.Manikin-based simulation

4.2.4.2.Surgical simulation

4.2.4.2.1.Market size and forecast

4.2.4.3.Ultrasound simulation

4.2.4.3.1.Market size and forecast

4.3.Web-based simulation

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type

4.3.4.1.Simulation software

4.3.4.1.1.Market size and forecast

4.3.4.2.Performance recording software

4.3.4.2.1.Market size and forecast

4.3.4.3.Virtual tutors

4.3.4.3.1.Market size and forecast

4.3.4.4.Learning management software

4.3.4.4.1.Market size and forecast

4.4.Simulation training services

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type

4.4.4.1.Vendor-based training

4.4.4.1.1.Market size and forecast

4.4.4.2.Custom consulting services

4.4.4.2.1.Market size and forecast

4.4.4.3.Educational societies

4.4.4.3.1.Market size and forecast

CHAPTER 5:GLOBAL MEDICAL SIMULATION MARKET, BY FIDELITY

5.1.Overview

5.1.1.Market size and forecast

5.2.Low-fidelity

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Medium-fidelity

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.High-fidelity

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

CHAPTER 6:GLOBAL MEDICAL SIMULATION MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Academic institutions

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Hospitals

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Military organizations

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:MEDICAL SIMULATION MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America medical simulation market, by product & service
7.2.3.North America medical simulation market, by fidelity
7.2.4.North America medical simulation market, by end user
7.2.5.Market size and forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.U.S. medical simulation market, by product & service
7.2.5.1.2.U.S. medical simulation market, by fidelity
7.2.5.1.3.U.S. medical simulation market, by end user

7.2.5.2.Canada

7.2.5.2.1.Canada medical simulation market, by product & service
7.2.5.2.2.Canada medical simulation market, by fidelity
7.2.5.2.3.Canada medical simulation market, by end user

7.2.5.3.Mexico

7.2.5.3.1.Mexico medical simulation market, by product & service
7.2.5.3.2.Mexico medical simulation market, by fidelity
7.2.5.3.3.Mexico medical simulation market, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe medical simulation market, by product & service
7.3.3.Europe medical simulation market, by fidelity
7.3.4.Europe medical simulation market, by end user
7.3.5.Market size and forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Germany medical simulation market, by product & service
7.3.5.1.2.Germany medical simulation market, by fidelity
7.3.5.1.3.Germany medical simulation market, by end user

7.3.5.2.France

7.3.5.2.1.France medical simulation market, by product & service
7.3.5.2.2.France medical simulation market, by fidelity
7.3.5.2.3.France medical simulation market, by end user

7.3.5.3.UK

7.3.5.3.1.UK medical simulation market, by product & service
7.3.5.3.2.UK medical simulation market, by fidelity
7.3.5.3.3.UK medical simulation market, by end user

7.3.5.4.Italy

7.3.5.4.1.Italy medical simulation market, by product & service
7.3.5.4.2.Italy medical simulation market, by fidelity
7.3.5.4.3.Italy medical simulation market, by end user

7.3.5.5.Spain

7.3.5.5.1.Spain medical simulation market, by product & service
7.3.5.5.2.Spain medical simulation market, by fidelity
7.3.5.5.3.Spain medical simulation market, by end user

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe medical simulation market, by product & service
7.3.5.6.2.Rest of Europe medical simulation market, by fidelity
7.3.5.6.3.Rest of Europe medical simulation market, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific medical simulation market, by product & service
7.4.3.Asia-Pacific medical simulation market, by fidelity
7.4.4.Asia-Pacific medical simulation market, by end user
7.4.5.Market size and forecast, by country

7.4.5.1.Japan

7.4.5.1.1.Japan medical simulation market, by product & service
7.4.5.1.2.Japan medical simulation market, by fidelity
7.4.5.1.3.Japan medical simulation market, by end user

7.4.5.2.China

7.4.5.2.1.China medical simulation market, by product & service
7.4.5.2.2.China medical simulation market, by fidelity
7.4.5.2.3.China medical simulation market, by end user

7.4.5.3.Australia

7.4.5.3.1.Australia medical simulation market, by product & service
7.4.5.3.2.Australia medical simulation market, by fidelity
7.4.5.3.3.Australia medical simulation market, by end user

7.4.5.4.India

7.4.5.4.1.India medical simulation market, by product & service
7.4.5.4.2.India medical simulation market, by fidelity
7.4.5.4.3.India medical simulation market, by end user

7.4.5.5.Rest of Asia-Pacific

7.4.5.5.1.Rest of Asia-Pacific medical simulation market, by product & service
7.4.5.5.2.Rest of Asia-Pacific medical simulation market, by fidelity
7.4.5.5.3.Rest of Asia-Pacific medical simulation market, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA medical simulation market, by product & service
7.5.3.LAMEA medical simulation market, by fidelity
7.5.4.LAMEA medical simulation market, by end user
7.5.5.Market size and forecast, by country

7.5.5.1.Brazil

7.5.5.1.1.Brazil medical simulation market, by product & service
7.5.5.1.2.Brazil medical simulation market, by fidelity
7.5.5.1.3.Brazil medical simulation market, by end user

7.5.5.2.Saudi Arabia

7.5.5.2.1.Saudi Arabia medical simulation market, by product & service
7.5.5.2.2.Saudi Arabia medical simulation market, by fidelity
7.5.5.2.3.Saudi Arabia medical simulation market, by end user

7.5.5.3.South Africa

7.5.5.3.1.South Africa medical simulation market, by product & service
7.5.5.3.2.South Africa medical simulation market, by fidelity
7.5.5.3.3.South Africa medical simulation market, by end user

7.5.5.4.Rest of LAMEA

7.5.5.4.1.Rest of LAMEA medical simulation market, by product & service
7.5.5.4.2.Rest of LAMEA medical simulation market, by fidelity
7.5.5.4.3.Rest of LAMEA medical simulation market, by end user

CHAPTER 8:COMPANY PROFILES

8.1.CAE INC.

8.1.1.Company overview

8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.GAUMARD SCIENTIFIC COMPANY

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments

8.3.INTELLIGENT ULTRASOUND GROUP PLC.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments

8.4.KYOTO KAGAKU CO. LTD.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio

8.5.LAERDAL MEDICAL AS

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Key strategic moves and developments

8.6.LIMBS AND THINGS LTD.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments

8.7.MENTICE AB

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.OPERATIVE EXPERIENCE, INC.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segment
8.8.4.Product portfolio
8.8.5.Key strategic moves and developments

8.9.SIMULAB CORPORATION

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Key strategic moves and developments

8.10.VIRTAMED AG

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segment
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCTS & SERVICES, 20202030 ($MILLION)
TABLE 02.MEDICAL SIMULATION MARKET FOR MODEL-BASED SIMULATION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03.GLOBAL MODEL-BASED SIMULATION MARKET, BY TYPE, 20202030 ($MILLION)
TABLE 04.GLOBAL PATIENT SIMULATION MARKET, BY TYPE, 20202030 ($MILLION)
TABLE 05.GLOBAL MANIKIN-BASED SIMULATION MARKET, BY TYPE, 20202030 ($MILLION)
TABLE 06.GLOBAL SURGICAL SIMULATION MARKET, BY TYPE, 20202030 ($MILLION)
TABLE 07.GLOBAL ULTRASOUND SIMULATION MARKET, BY TYPE, 20202030 ($MILLION)
TABLE 08.MEDICAL SIMULATION MARKET FOR WEB-BASED SIMULATION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 09.GLOBAL WEB-BASED MEDICAL SIMULATION MARKET, BY TYPE, 20202030($MILLION)
TABLE 10.GLOBAL SIMULATION SOFTWARE MARKET, 20202030 ($MILLION)
TABLE 11.GLOBAL PERFORMANCE RECORDING SOFTWARE MARKET, 20202030 ($MILLION)
TABLE 12.GLOBAL VIRTUAL TUTORS MARKET, 20202030 ($MILLION)
TABLE 13.GLOBAL LEARNING MANAGEMENT SOFTWARE MARKET, 20202030 ($MILLION)
TABLE 14.MEDICAL SIMULATION MARKET FOR SIMULATION TRAINING SERVICES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 15.GLOBAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20202030 ($MILLION)
TABLE 16.GLOBAL VENDOR-BASED TRAINING MARKET, 20202030 ($MILLION)
TABLE 17.GLOBAL CUSTOM CONSULTING SERVICES MARKET, 20202030 ($MILLION)
TABLE 18.GLOBAL EDUCATIONAL SOCIETIES MARKET, 20202030 ($MILLION)
TABLE 19.GLOBAL MEDICAL SIMULATION MARKET, BY FIDELITY, 20202030 ($MILLION)
TABLE 20.GLOBAL MEDICAL SIMULATION MARKET FOR LOW-FIDELITY, BY REGION, 20202030($MILLION)
TABLE 21.GLOBAL MEDICAL SIMULATION MARKET FOR MEDIUM-FIDELITY, BY REGION, 20202030($MILLION)
TABLE 22.GLOBAL MEDICAL SIMULATION MARKET FOR HIGH-FIDELITY, BY REGION, 20202030 ($MILLION)
TABLE 23.GLOBAL MEDICAL SIMULATION MARKET, BY END USER 20202030 ($MILLION)
TABLE 24.GLOBAL MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTIONS, BY REGION, 20202030 ($MILLION)
TABLE 25.GLOBAL MEDICAL SIMULATION MARKET FOR HOSPITALS, BY REGION, 20202030($MILLION)
TABLE 26.GLOBAL MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY REGION, 20202030($MILLION)
TABLE 27.MEDICAL SIMULATION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 28.NORTH AMERICA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 29.NORTH AMERICA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 30.NORTH AMERICA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31.NORTH AMERICA MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32.U.S. MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 33.U.S. MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 34.U.S. MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35.CANADA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 36.CANADA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 37.CANADA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38.MEXICO MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 39.MEXICO MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 40.MEXICO MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 41.EUROPE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 42.EUROPE MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 43.EUROPE MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44.EUROPE MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 45.GERMANY MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 46.GERMANY MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 47.GERMANY MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48.FRANCE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 49.FRANCE MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 50.FRANCE MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 51.UK MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 52.UK MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 53.UK MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 54.ITALY MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 55.ITALY MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 56.ITALY MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57.SPAIN MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 58.SPAIN MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 59.SPAIN MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60.REST OF EUROPE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 61.REST OF EUROPE MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 62.REST OF EUROPE MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 63.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 64.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 65.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 66.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 67.JAPAN MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 68.JAPAN MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 69.JAPAN MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 70.CHINA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 71.CHINA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 72.CHINA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 73.AUSTRALIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 74.AUSTRALIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 75.AUSTRALIA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 76.INDIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 77.INDIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 78.INDIA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 79.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 80.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 81.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 82.LAMEA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 83.LAMEA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 84.LAMEA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85.LAMEA MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 86.BRAZIL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 87.BRAZIL MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 88.BRAZIL MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 89.SAUDI ARABIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 90.SAUDI ARABIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 91.SAUDI ARABIA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 92.SOUTH AFRICA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 93.SOUTH AFRICA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 94.SOUTH AFRICA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 95.REST OF LAMEA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 96.REST OF LAMEA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 97.REST OF LAMEA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 98.CAE: COMPANY SNAPSHOT
TABLE 99.CAE: OPERATING SEGMENTS
TABLE 100.CAE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 101.CAE: KEY DEVELOPMENTS
TABLE 102.GAUMARD: COMPANY SNAPSHOT
TABLE 103.GAUMARD: OPERATING SEGMENTS
TABLE 104.GAUMARD: PRODUCT PORTFOLIO
TABLE 105.GAUMARD: KEY DEVELOPMENTS
TABLE 106.INTELLIGENT: COMPANY SNAPSHOT
TABLE 107.INTELLIGENT: OPERATING SEGMENTS
TABLE 108.INTELLIEGENT: PRODUCT PORTFOLIO
TABLE 109.INTELLIGENT: KEY DEVELOPMENTS
TABLE 110.KYOTO KAGAKU: COMPANY SNAPSHOT
TABLE 111.KYOTO KAGAKU: OPERATING SEGMENTS
TABLE 112.KYOTO KAGAKU: PRODUCT PORTFOLIO
TABLE 113.LAERDAL: COMPANY SNAPSHOT
TABLE 114.LAERDAL: OPERATING SEGMENTS
TABLE 115.LAERDAL: PRODUCT PORTFOLIO
TABLE 116.LAERDAL: KEY DEVELOPMENTS
TABLE 117.LIMBS & THINGS: COMPANY SNAPSHOT
TABLE 118.LIMBS & THINGS: OPERATING SEGMENTS
TABLE 119.LIMBS & THINGS: PRODUCT PORTFOLIO
TABLE 120.LIMBS & THINGS: KEY DEVELOPMENTS
TABLE 121.MENTICE: COMPANY SNAPSHOT
TABLE 122.MENTICE: OPERATING SEGMENTS
TABLE 123.MENTICE: PRODUCT PORTFOLIO
TABLE 124.MENTICE: KEY DEVELOPMENTS
TABLE 125.OPERATIVE: COMPANY SNAPSHOT
TABLE 126.OPERATIVE: OPERATING SEGMENTS
TABLE 127.OPERATIVE: PRODUCT PORTFOLIO
TABLE 128.OPERA

Major Companies

  • CAE, Inc.
  • Gaumard Scientific Company, Inc.
  • Intelligent Ultrasound Group Plc.
  • Inovus
  • Synaptive Medical
  • Kyoto Kagaku Co. Ltd.
  • Laerdal Medical AS
  • HRV Simulation
  • Surgical Science
  • Limbs and Things, Ltd.
  • Mentice AB
  • Operative Experience, Inc.
  • Simulab Corporation
  • VirtaMed AG
  • Others

Segmentation

By Product & Services

  • Model-based Simulation
    • Patient Simulation
      • Task Trainer Simulation
      • Manikin-based Simulation
        • Adult
        • Pediatric
        • Neonatal
      • Hybrid Manikin-based simulation (with AR)
      • Standardized Patient Simulation
    • Surgical Simulation
      • Laparoscopic Surgical Simulators
      • Arthroscopic Surgical Simulators
      • Cardiovascular Simulators
      • Gynecology Simulators
      • Orthopedic Simulators
      • Spine Simulators
      • Endovascular Simulators
      • Others
    • Ultrasound Simulation
      • Anesthesia
      • Cardiology
      • Emergency Medicine
      • Intensive Care Unit
      • OB/GYN
      • Radiology
      • Others (Urology, General Nursing, Pediatrics)
    • Web-based Simulation
      • Simulation Software
      • Performance Recording Software
      • Virtual Tutors
      • Learning Management Software
    • Simulation Training Services
    • Vendor-based Training
    • Custom Consulting Services
    • Educational Societies

By Fidelity

  • Low-fidelity
  • Medium-fidelity
  • High-fidelity

By End User

  • Academic Institutions
  • Hospitals
  • Military Organizations

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF